Alnylam
FeaturedFinanceIndustry NewsLife Science
Life Science Reality Check: Alexandria’s Q1 Performance Reflects Industry Challenges Despite Executive Optimism
Alexandria Real Estate Equities (ARE), a pure-play life science REIT, reported its Q1 2025 earnings on April 29th with mixed results that suggest...
AECFeaturedFinanceIndustry NewsLife Science
Alexandria Real Estate Plans an Accelerated Disposition Strategy for 2025
Alexandria Real Estate Equities, Inc. (NYSE: ARE) is executing an ambitious disposition strategy in 2025 as it faces headwinds in the life science...
